SOPW, revenue $26M, net loss $0.02/shr, the street gives it a $862M market cap.
JASO, revenue $492M, net profit $0.21/shr, the street gives it a $460M market cap.
Why do they need another offering with the current amount of cash on hand?
Check back your saved tax filing document, then get back to tell us the symbol.
1) OXGN is not marginable, so the drop does not incur margin call;
2) By now, longs only have $2.15/share too loose, but can be over 10 times more to gain;
3) Clinical results till now are in longs' favor.
With so low share ownership by the management, the CEO has no incentive to increase the share price, actually, it's to their interest to make the price lower, because then they can buy in cheap.
No that you have disclosed your bottom line, then they'll push it down to make sure to get it at $1.9.
No. From level 2, the price increased with large volume, some body just tried to walk it down with much smaller volume, but he/she won't get too much time left.